Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.
Plastic surgeon Johnny Franco, MD, discusses how his firsthand experience with GLP-1s shaped his patient-centered wellness program and what plastic surgeons should know before adding similar treatments to their aesthetic practices.